CLOV vs LH · rev $1.37B vs P/E 23, rev $13.01B
Clover Health Investments Corp (CLOV) versus Laboratory Corporation of America Holdings (LH) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Laboratory Corporation of America Holdings (LH) is a diagnostics & research company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported LH revenue for 2024-12-31 was $13.01B. Net income was $747.1M. Revenue was up 7.0% from 2023-12-31 to 2024-12-31. LH currently screens at market cap $21.07B and trailing P/E 22.8.
CLOV currently screens at market cap $1.55B. LH currently screens at market cap $21.07B and trailing P/E 22.8.
Not investment advice. Open the CLOV and LH stock pages for the full models.
Not investment advice.